S&P 500   4,701.21 (+0.31%)
DOW   35,754.75 (+0.10%)
QQQ   399.61 (+0.45%)
AAPL   175.08 (+2.28%)
MSFT   334.97 (+0.01%)
FB   330.56 (+2.40%)
GOOGL   2,963.73 (+0.62%)
AMZN   3,523.16 (+0.00%)
TSLA   1,068.96 (+1.64%)
NVDA   318.26 (-1.85%)
BABA   125.08 (-0.37%)
NIO   35.05 (+5.83%)
CGC   10.94 (+2.82%)
AMD   145.24 (+0.27%)
GE   98.28 (+0.75%)
MU   86.02 (+0.22%)
T   23.17 (+0.39%)
F   19.81 (-0.75%)
DIS   153.34 (+1.68%)
PFE   51.40 (-0.62%)
AMC   32.35 (+4.22%)
ACB   6.57 (+2.98%)
BA   211.03 (+1.05%)
S&P 500   4,701.21 (+0.31%)
DOW   35,754.75 (+0.10%)
QQQ   399.61 (+0.45%)
AAPL   175.08 (+2.28%)
MSFT   334.97 (+0.01%)
FB   330.56 (+2.40%)
GOOGL   2,963.73 (+0.62%)
AMZN   3,523.16 (+0.00%)
TSLA   1,068.96 (+1.64%)
NVDA   318.26 (-1.85%)
BABA   125.08 (-0.37%)
NIO   35.05 (+5.83%)
CGC   10.94 (+2.82%)
AMD   145.24 (+0.27%)
GE   98.28 (+0.75%)
MU   86.02 (+0.22%)
T   23.17 (+0.39%)
F   19.81 (-0.75%)
DIS   153.34 (+1.68%)
PFE   51.40 (-0.62%)
AMC   32.35 (+4.22%)
ACB   6.57 (+2.98%)
BA   211.03 (+1.05%)
S&P 500   4,701.21 (+0.31%)
DOW   35,754.75 (+0.10%)
QQQ   399.61 (+0.45%)
AAPL   175.08 (+2.28%)
MSFT   334.97 (+0.01%)
FB   330.56 (+2.40%)
GOOGL   2,963.73 (+0.62%)
AMZN   3,523.16 (+0.00%)
TSLA   1,068.96 (+1.64%)
NVDA   318.26 (-1.85%)
BABA   125.08 (-0.37%)
NIO   35.05 (+5.83%)
CGC   10.94 (+2.82%)
AMD   145.24 (+0.27%)
GE   98.28 (+0.75%)
MU   86.02 (+0.22%)
T   23.17 (+0.39%)
F   19.81 (-0.75%)
DIS   153.34 (+1.68%)
PFE   51.40 (-0.62%)
AMC   32.35 (+4.22%)
ACB   6.57 (+2.98%)
BA   211.03 (+1.05%)
S&P 500   4,701.21 (+0.31%)
DOW   35,754.75 (+0.10%)
QQQ   399.61 (+0.45%)
AAPL   175.08 (+2.28%)
MSFT   334.97 (+0.01%)
FB   330.56 (+2.40%)
GOOGL   2,963.73 (+0.62%)
AMZN   3,523.16 (+0.00%)
TSLA   1,068.96 (+1.64%)
NVDA   318.26 (-1.85%)
BABA   125.08 (-0.37%)
NIO   35.05 (+5.83%)
CGC   10.94 (+2.82%)
AMD   145.24 (+0.27%)
GE   98.28 (+0.75%)
MU   86.02 (+0.22%)
T   23.17 (+0.39%)
F   19.81 (-0.75%)
DIS   153.34 (+1.68%)
PFE   51.40 (-0.62%)
AMC   32.35 (+4.22%)
ACB   6.57 (+2.98%)
BA   211.03 (+1.05%)
OTCMKTS:GNGBY

Getinge Stock Forecast, Price & News

$43.55
+1.79 (+4.29%)
(As of 12/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$42.84
$43.79
50-Day Range
$39.26
$48.80
52-Week Range
$21.26
$48.89
Volume
59,735 shs
Average Volume
3,536 shs
Market Capitalization
$11.07 billion
P/E Ratio
30.67
Dividend Yield
0.62%
Beta
0.92
30 days | 90 days | 365 days | Advanced Chart
Receive GNGBY News and Ratings via Email

Sign-up to receive the latest news and ratings for Getinge and its competitors with MarketBeat's FREE daily newsletter.


Getinge logo

About Getinge

Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. It engages in supplying of solutions for theaters, intensive care units, sterilization centers and companies and institutions within life science. The company was founded by Olander Larsson in 1904 and is headquartered in Gothenburg, Sweden.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:GNGBY
CIK
N/A
Employees
10,818
Year Founded
N/A

Sales & Book Value

Annual Sales
$3.25 billion
Cash Flow
$2.86 per share
Book Value
$10.94 per share

Profitability

Net Income
$353.05 million
Pretax Margin
16.31%

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$11.07 billion
Optionable
Not Optionable

Company Calendar

Today
12/08/2021
Fiscal Year End
12/31/2021

MarketRank

Overall MarketRank

1.25 out of 5 stars

Analyst Opinion: 1.3Community Rank: 4.1Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Getinge (OTCMKTS:GNGBY) Frequently Asked Questions

Is Getinge a buy right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Getinge in the last twelve months. There are currently 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Getinge stock.
View analyst ratings for Getinge
or view top-rated stocks.

How has Getinge's stock been impacted by COVID-19 (Coronavirus)?

Getinge's stock was trading at $16.29 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, GNGBY shares have increased by 167.3% and is now trading at $43.55.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Getinge?

Getinge saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 200 shares, a decrease of 71.4% from the October 31st total of 700 shares. Based on an average daily trading volume, of 15,900 shares, the short-interest ratio is presently 0.0 days.
View Getinge's Short Interest
.

How often does Getinge pay dividends? What is the dividend yield for Getinge?

Getinge declared a dividend on Saturday, March 13th. Shareholders of record on Thursday, April 22nd will be given a dividend of $0.5226 per share on Wednesday, May 12th. This represents a yield of 2.08%. The ex-dividend date is Wednesday, April 21st.
View Getinge's dividend history
.

Is Getinge a good dividend stock?

Getinge pays an annual dividend of $0.26 per share and currently has a dividend yield of 0.62%. The dividend payout ratio of Getinge is 18.31%. This payout ratio is at a healthy, sustainable level, below 75%.
View Getinge's dividend history.

What price target have analysts set for GNGBY?

9 Wall Street analysts have issued 12-month price objectives for Getinge's shares. Their forecasts range from $41.32 to $41.32. On average, they anticipate Getinge's stock price to reach $41.32 in the next twelve months. This suggests that the stock has a possible downside of 5.1%.
View analysts' price targets for Getinge
or view top-rated stocks among Wall Street analysts.

Who are Getinge's key executives?

Getinge's management team includes the following people:
  • Mattias Sven Perjos, President, Chief Executive Officer & Director
  • Lars Sandström, Chief Financial Officer
  • Anna Romberg, Executive VP-Legal, Compliance & Governance
  • Carsten Blecker, Chief Commercial Officer
  • Jens Viebke, President-Acute Care Therapies Business

What is Getinge's stock symbol?

Getinge trades on the OTCMKTS under the ticker symbol "GNGBY."

How do I buy shares of Getinge?

Shares of GNGBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Getinge's stock price today?

One share of GNGBY stock can currently be purchased for approximately $43.55.

How much money does Getinge make?

Getinge has a market capitalization of $11.07 billion and generates $3.25 billion in revenue each year. The company earns $353.05 million in net income (profit) each year or $1.42 on an earnings per share basis.

How many employees does Getinge have?

Getinge employs 10,818 workers across the globe.

What is Getinge's official website?

The official website for Getinge is www.getinge.com.

Where are Getinge's headquarters?

Getinge is headquartered at LINDHOLMSPIREN 7A, GOTHENBURG V7, 41756.

How can I contact Getinge?

Getinge's mailing address is LINDHOLMSPIREN 7A, GOTHENBURG V7, 41756. The company can be reached via phone at (610) 335-0000, via email at [email protected], or via fax at 46-1-033-556-40.


This page was last updated on 12/8/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.